Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: the Gemi-Heart study.
Seung Min ChungJun Sung MoonJun Hwa HongIn-Chang HwangSoo LimPublished in: Diabetes, obesity & metabolism (2023)
ClinicalTrials.gov NCT05663736 This article is protected by copyright. All rights reserved.
Keyphrases